Linking Initiatives to Real-World Outcomes

Success Story




Automated Migration Assessment in the Pharmaceuticals Industry

At a Glance

Company Profile

  • Top 20 leading Pharma company

  • 146 affiliates

  • 47,700 employees

  • Key areas: respiratory diseases, metabolism, immunology, oncology, and central nervous system diseases

  • Member of the European Federation of Pharmaceutical Industries and Associations (EFPIA)Street People



5 years ago, Boehringer Ingelheim used the SAP Ramp- Up program at an early stage, to gain a strong voice on international industry standards committees. Today, their SAP systems cover almost all requirements. These requirements include improved patient safety through increased transparency in the supply chain, globally consistent serial numbers and standardized data, and innovation leadership on the process side.


Completed West Trax automated assessment, preparing multi-year subscription to KPI Analyzer.

Budgeting and project plans are underway to move to SAP S/4HANA, as a result of their completed West Trax analysis. West Trax ensures full compliancy with all technical and business standards maintained by the client, which enables a seamless migration using all the facts produced in the assessment.       


Cut Time & Costs

The West Trax Assessment KPI Analyzer – the innovation App – cuts 99% of the time and > 70% of costs of assessment workshops.

Automated Methodology

Proven to mitigate risk of human error and subjectivity, used by 1,800+ SAP customers.

"With a West Trax analysis, we can eliminate a lot of customization in our SAP systems. Thus, we have implemented the future readiness of our SAP systems - especially with regard to a future migration to S/4 Hana etc. Several of our systems have qualified for a West Trax Quality Award."

Andreas Henrich

Boehringer Ingelheim Pharma


Reference Videos


For more information, contact:

President & CEO

West Trax KPI Analyzer Representatives for North America/Exclusive Agents in Canada

© West Trax/BTT 2024. All rights reserved.

© 2018-2024 Acquired Insights Inc. Privacy Policy I Terms of Use